Innovative OTC Stock Analysis

IMTH -  USA Stock  

USD 1.84  0.58  46.03%

The current price rise of Innovative Medtech may raise some interest from stockholders. The stock closed today at a share price of 1.84 on 8,683 in trading volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in February. The stock standard deviation of daily returns for 90 days investing horizon is currently 61.22. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Innovative Medtech partners.
Please see Risk vs Return Analysis.

Innovative O TC Stock Analysis 

 
Refresh
The Innovative Medtech otc stock analysis report makes it easy to digest most publicly released information about Innovative Medtech and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Innovative OTC Stock analysis module also helps to analyze the Innovative Medtech price relationship with some important fundamental indicators such as market cap and management efficiency.

Innovative OTC Stock Analysis Notes

About 85.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.56. Innovative Medtech had not issued any dividends in recent years. The entity had a split on the 9th of March 2021. Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.The quote for Innovative Medtech is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Innovative Medtech call the company at 708 925 9424 or check out https://innovativemedtechinc.com.

Innovative Medtech Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Innovative Medtech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Innovative Medtech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Innovative Medtech is way too risky over 90 days horizon
Innovative Medtech may become a speculative penny stock
Innovative Medtech appears to be risky and price may revert if volatility continues
The company currently holds 2.13 M in liabilities. Innovative Medtech has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 665.71 K. Net Loss for the year was (3.29 M) with profit before overhead, payroll, taxes, and interest of 349.14 K.
Innovative Medtech currently holds about 106.83 K in cash with (142.73 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 85.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Alabama Department of Public Health Partners with Innovative Health Tech Continuing Education Provider for Radiation Control Training and Safety - Yahoo Finance

Innovative Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 26.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innovative Medtech's market, we take the total number of its shares issued and multiply it by Innovative Medtech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (16.9) % which means that it has lost $16.9 on every $100 spent on asset. This is way below average. Innovative Medtech management efficiency ratios could be used to measure how well innovative medtech manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 27th of January, Innovative Medtech retains the Market Risk Adjusted Performance of 1.5, downside deviation of 36.18, and Risk Adjusted Performance of 0.1522. Innovative Medtech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Innovative Medtech, which can be compared to its competitors. Please check out Innovative Medtech coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Innovative Medtech is priced fairly, providing market reflects its last-minute price of 1.84 per share. Please also validate Innovative Medtech total risk alpha, which is currently at 15.38 to confirm the company can sustain itself at a future point.

Innovative Medtech Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Triangular Moving Average shows Innovative Medtech double smoothed mean price over a specified number of previous prices (i.e., averaged twice). View also all equity analysis or get more info about triangular moving average overlap studies indicator.

Innovative Medtech Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innovative Medtech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innovative Medtech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innovative Medtech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Friedman Michael Jordan over a week ago via Macroaxis 
Innovative Medtech exotic insider transaction detected

Innovative Medtech Predictive Daily Indicators

Innovative Medtech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Innovative Medtech otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Innovative Medtech Forecast Models

Innovative Medtech time-series forecasting models is one of many Innovative Medtech's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Innovative Medtech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Innovative OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Innovative Medtech stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Innovative shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Innovative Medtech. By using and applying Innovative OTC Stock analysis, traders can create a robust methodology for identifying Innovative entry and exit points for their positions.
Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Innovative Medtech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.